vaccinia
viru
prototyp
poxvirida
larg
dna
viru
replic
cytoplasm
host
cell
assembl
pathway
vaccinia
viru
display
sever
uniqu
featur
product
two
structur
distinct
infecti
form
one
term
intracellular
nake
viru
inv
remain
cell
associ
term
extracellular
envelop
viru
eev
releas
cell
addit
long
believ
inv
acquir
lipid
envelop
uniqu
exampl
de
novo
membran
biogenesi
examin
structur
assembl
vaccinia
viru
use
immunoelectron
microscopi
use
antibodi
protein
differ
subcellular
compart
well
phospholipid
analysi
purifi
inv
eev
abbrevi
use
paper
eev
extracellular
envelop
viru
ibv
avian
infecti
bronchiti
viru
iev
intracellular
envelop
viru
imv
intracellular
matur
viru
inv
intracellular
nake
viru
moi
multipl
infect
pdi
protein
disulfid
isomeras
pfu
plaqu
form
unit
pi
postinfect
slo
streptolysin
vv
vaccinia
viru
data
consist
de
novo
model
viral
membran
synthesi
rather
argu
vaccinia
viru
dna
becom
enwrap
membran
cisterna
deriv
intermedi
compart
er
golgi
stack
thu
acquir
two
membran
one
step
phospholipid
analysi
purifi
inv
support
deriv
earli
biosynthet
compart
uniqu
assembl
process
repeat
inv
becom
enwrap
addit
membran
cisterna
agreement
earlier
report
avail
data
suggest
fusion
outer
envelop
plasma
membran
matur
eev
releas
cell
v
accinia
viru
best
studi
member
famili
poxvirida
largest
complex
anim
virus
review
see
dale
pogo
fenner
et
al
moss
doublestrand
linear
dna
genom
kbp
sequenc
potenti
gene
identifi
goebel
et
al
unlik
dna
virus
vaccinia
viru
replic
assembl
cytoplasm
host
cell
replic
assembl
occur
discret
cytoplasm
foci
term
viral
factori
thought
devoid
cellular
organel
membran
joklik
becker
assembl
first
manifest
appear
crescentshap
membran
within
viral
factori
membran
eventu
form
spheric
immatur
virion
undergo
addit
matur
event
includ
cleavag
viral
core
protein
moss
rosenblum
give
rise
first
infecti
brickshap
form
vaccinia
viru
dale
pogo
viral
form
far
best
character
long
refer
intracellular
nake
viru
inv
despit
fact
bound
least
one
lipid
envelop
phospholipid
compris
inv
weight
zwartouw
disrupt
envelop
nonion
deterg
increas
appar
densiti
cesium
chlorid
gradient
dom
et
al
variabl
amount
inv
thought
transport
golgi
region
cell
ichihashi
et
al
morgan
hiller
weber
enwrap
membran
cisterna
avail
data
argu
enwrap
form
viru
lose
outermost
two
newli
acquir
bilay
fuse
plasma
membran
releas
medium
dale
pogo
fenner
et
al
second
infecti
form
viru
term
extracellular
envelop
viru
eev
contain
addit
polypeptid
compar
inv
payn
import
dissemin
vaccinia
cell
cultur
host
anim
payn
payn
kristensson
moss
number
studi
vaccinia
assembl
dale
mossbach
dale
pogo
petterson
given
rise
model
viral
particl
obtain
first
membran
process
involv
de
novo
membran
biogenesi
see
palad
true
would
markedli
differ
cellular
membran
thought
synthes
templat
organel
predominantli
er
palad
dawidowicz
bishop
bell
well
envelop
virus
acquir
membran
cellular
organel
stephen
compan
petterson
griffith
rottier
evid
de
novo
biogenesi
model
deriv
larg
convent
electron
microscop
studi
show
end
form
crescentshap
viral
membran
without
obviou
continu
cellular
organel
dale
mossbach
nagayama
et
al
although
precis
model
put
forward
de
novo
mechan
basic
assumpt
viral
membran
protein
cellular
lipid
assembl
lipid
bilay
vaccinia
encod
enzym
stem
dale
stern
dale
studi
vaccinia
viru
assembl
far
reli
classic
electron
microscop
techniqu
use
plastic
embed
sampl
examin
vaccinia
viru
assembl
particular
deriv
viral
membran
inv
made
immunocytochem
analysi
vacciniainfect
tissu
cultur
cell
use
thaw
cryosect
examin
ultrastructur
vaccinia
particl
perform
immunoloc
ultrastructur
level
tokuyasu
tokuyasu
thaw
cryosect
fix
cell
well
gradient
purifi
virion
show
inv
form
vaccinia
viru
contain
two
eev
form
three
membran
use
antibodi
sever
marker
protein
subceuular
compart
compar
local
assembl
viral
particl
data
suggest
vaccinia
viru
use
uniqu
assembl
pathway
unlik
envelop
virus
acquir
singl
membran
bud
cellular
organel
vaccinia
viru
becom
enwrap
membran
cistema
therebi
acquir
two
membran
simultan
remain
free
cytoplasm
membran
cisterna
origin
de
novo
rather
deriv
intermedi
compart
er
golgi
stack
hela
cell
grown
mem
supplement
fc
heat
inactiv
nonessenti
amino
acid
cell
glasgow
minimum
essenti
medium
gmem
supplement
fc
tryptos
phosphat
broth
mous
macrophag
dme
supplement
fc
media
contain
uml
penicillin
ttgml
streptomycin
mm
glutamin
cell
line
grown
adher
cultur
c
h
incub
c
tissu
cultur
reagent
obtain
gibco
gibco
brl
gaithersburg
md
studi
use
wildtyp
vaccinia
viru
strain
wwr
wildtyp
vaccinia
viru
strain
vvihdj
recombin
vaccinia
viru
express
glycoprotein
avian
infecti
bronchiti
viru
macham
rose
viru
propag
titrat
perform
previous
describ
earl
moss
inv
eev
purifi
ihdj
infect
cell
separ
cesium
chlorid
sucros
densiti
gradient
previous
describ
dom
et
al
cell
grown
confluenc
infect
coverslip
immunofluoresc
plastic
tissu
cultur
dish
em
cell
infect
serumfre
media
multipl
infect
moi
plaqu
form
unit
per
cell
pfucel
h
intermitt
agit
inocnium
aspir
cell
wash
pb
place
complet
growth
media
c
without
rifampicin
fire
mgml
sigma
immunochem
st
loui
mo
rifampicin
store
stock
solut
dmso
c
chase
experi
cell
wash
three
time
ice
cold
pb
indic
time
incub
drugfre
medium
c
cycloheximid
use
indic
hela
bhk
cell
grown
coverslip
light
microscopi
infect
vvwr
pfuce
fix
h
interv
h
postinfect
pi
viral
dna
replic
monitor
use
fluoresc
dna
stain
see
synchron
infect
low
cytopath
effect
h
pi
achiev
infect
pfueeil
em
see
hela
cell
infect
wwr
moi
pfucel
fix
interv
h
pi
h
pi
immatur
virus
alreadi
form
cell
h
pi
cell
within
one
section
show
differ
viral
structur
often
within
one
cell
experi
describ
studi
therefor
carri
cell
infect
pfucel
h
pi
viral
structur
character
em
alreadi
form
wherea
cytopath
effect
minim
tabl
show
list
antigen
marker
use
studi
antibodi
use
cellular
marker
protein
character
previous
see
tabl
refer
tdna
igm
obtain
mous
mab
igm
polyclon
rabbit
serum
polyclon
rabbit
serum
affin
purifi
rabbit
ctpeptid
serum
acterminu
mous
mab
igg
rabbit
ctpeptid
acterminu
affin
purifi
rabbit
tfusion
protein
affin
purifi
mous
mab
igg
rabbit
polyelon
serum
affin
purifi
rabbit
tpeptid
acterminu
affin
purifi
hausmann
et
al
burk
et
al
roth
berger
prehn
et
al
tooz
et
al
chavrier
et
al
schweizer
et
al
sarast
et
al
macham
rose
journal
cell
biolog
volum
boehring
marmheim
gmbh
mannheim
germani
antibodi
gift
follow
sourc
b
burk
harvard
univers
cambridg
cxmannosidas
ii
e
berger
univers
ziirich
switzerland
prehn
rapoport
maxdelbriick
institut
germani
p
buck
fuller
embl
germani
zerial
embl
heidelberg
germani
h
p
hauri
biozentrum
switzerland
j
sarast
univers
bergen
norway
secondari
antibodi
rhodamin
fitc
coupl
goat
antirabbit
igg
goat
antimous
igg
goat
antimous
igm
immunofluoresc
rabbit
antimous
igg
rabbit
antimous
igm
rabbit
antirat
igg
immuncelectron
microscopi
obtain
organon
technikacappel
west
chester
pa
vivo
label
experi
transgolgitransgolgi
network
label
describ
kobayashi
pagano
use
fluoresc
kindli
provid
kobayashi
tohoku
univers
japan
incub
immunofluoresc
label
carri
pb
ph
room
temperatur
infect
bhk
hela
cell
fix
indic
time
paraformaldehyd
rain
wash
pb
remain
fix
quench
mm
min
cell
permeabil
triton
rain
wash
transfer
gelatin
label
primari
antibodi
gelatin
rain
coverslip
rins
three
time
rain
incub
fluoresc
label
secondari
antibodi
gelatin
rain
doublelabel
experi
two
primari
two
secondari
antibodi
appli
togeth
local
cell
permeabil
saponin
mm
kpipe
ph
mm
egta
mm
min
fixat
wash
cytosol
nonmembranebound
protein
label
essenti
perform
describ
chavrier
et
ai
nuclear
viral
dna
visual
stain
tgmi
bisbenzimid
hoechst
fix
cell
membran
permeabl
hoechst
live
cell
sigma
immunochemicai
rain
extens
wash
pb
coverslip
mount
glass
slide
use
moviol
mount
medium
examin
axiophot
fluoresc
microscop
carl
zeiss
inc
oberkochen
germani
vacciniainfect
bhk
hela
cell
fix
min
glutaraldehyd
cacodyl
buffer
ph
stain
cn
follow
magnesium
uranylacet
min
respect
process
convent
epon
embed
incub
carri
room
temperatur
immunoelectron
microscopi
infect
cell
remov
tissu
cultur
dish
treat
proteinas
k
tzgml
hela
bhk
merck
darmstadt
germani
ice
min
mm
edta
ice
min
mous
macrophag
cell
purifi
inv
eev
band
collect
sucros
gradient
hand
cell
viru
sampl
prefix
paraformaldehyd
pfa
hepe
ph
spun
g
fix
pfa
hepe
ph
overnight
spun
g
min
pellet
infiltr
sucros
cryoprotect
pb
x
rain
frozen
liquid
nitrogen
ultrathin
section
cut
transfer
formvar
coat
emgrid
immunolabel
well
dri
contrast
section
perform
describ
grittith
et
al
grittith
et
al
quantit
electron
micrograph
taken
systemat
fashion
primari
magnif
densiti
gold
label
virion
nucleu
cytoplasm
area
around
virion
quantifi
point
count
griflith
hoppel
adher
hela
cell
infect
vvwr
mo
pfucel
either
without
rifampicin
follow
lh
chase
streptolysin
slo
permeabil
h
pi
cell
transfer
onto
ice
wash
ice
cold
slobuff
mm
sucros
mm
magnesium
acet
mm
potassium
acet
mm
hepe
ph
mm
dtt
incub
ice
uml
slo
wellcom
diagnost
england
slobuff
mm
dish
rain
bind
slo
plasma
membran
cell
wash
ice
cold
slobuff
incub
min
allow
pore
format
slo
transfer
back
onto
ice
condit
cellular
lactat
dehydrogenas
releas
medium
prepar
broken
cell
h
ceil
care
scrape
media
colfecwxl
pellet
inin
g
subsequ
step
carri
infect
cell
wash
pb
resuspend
mm
dish
break
buffer
sucros
mm
imidazol
ph
gentli
broken
pipet
twice
small
yellow
pipett
tip
gilson
medic
elec
inc
middleton
wl
select
perfor
plasma
membran
condit
cell
broken
judg
trypan
blue
stain
broken
cell
retain
major
cytoplasm
organel
includ
viral
factori
broken
cell
pool
rain
g
resuspend
ml
incub
buffer
sucros
mm
hepe
ph
mm
magnesium
acet
mm
potassium
acet
contain
nm
bsagold
final
od
rain
contain
proteinas
k
merck
darmstadt
germani
mgml
rain
follow
pmsf
final
mgml
min
slopermeabil
broken
cell
fix
glutaraidehyd
cacodyl
buffer
ph
h
process
epon
embed
subconflu
flask
cell
incub
h
lowphosph
medium
contain
mci
new
england
nuclear
bad
homburg
germani
without
serum
van
meer
simon
label
cellular
phospholipid
cell
infect
ihdj
pfucel
addit
viru
fc
directli
label
medium
h
inv
eev
harvest
cell
medium
purifi
cesium
chlorid
gradient
dona
et
al
gradient
fraction
radioact
peak
pool
label
acet
ad
cell
time
infect
last
h
lipid
extract
analyz
twodimension
high
perform
thin
layer
chromatographi
describ
van
meer
simon
except
radioact
spot
plate
local
autoradiographi
colocai
unlabel
carrier
lipid
iodin
stain
sampl
analyz
duplic
data
tabl
u
express
mean
standard
error
mean
vaccinia
viru
replic
assembl
occur
discret
cytoplasm
structur
term
viral
factori
moss
sinc
wellcharacter
marker
protein
structur
describ
identifi
use
marker
dna
esteban
bisbenzimid
fluoresc
dna
stain
detect
viral
factori
per
cell
h
pi
coalesc
one
two
larg
juxtanuclear
factori
h
pi
em
cryosect
infect
hela
cell
label
antidna
antibodi
hausmann
et
al
nuclei
cytoplasm
area
contain
crescent
shape
membran
well
discret
immatur
virion
fig
decor
protein
agold
dna
within
virion
could
also
label
fig
arrow
howev
cytoplasm
area
label
antidna
antibodi
much
larger
area
viral
crescent
form
addit
crescent
well
iv
label
dna
conclud
part
cytoplasm
fluoresc
seen
stain
dna
stain
correspond
cytoplasm
assembl
site
vaccinia
viru
observ
em
first
distinct
structur
assembl
viru
crescentshap
membran
locat
within
viral
factori
show
brushlik
array
electrondens
spicul
convex
surfac
dale
mossbach
close
inspect
reveal
membran
structur
close
proxim
fig
even
continu
fig
e
crescent
membran
within
viral
factori
better
visual
cryosect
also
reveal
within
crescent
second
membran
could
often
detect
fig
b
g
epon
section
infect
cell
two
membran
difficult
resolv
see
topolog
viru
assembl
occasion
howev
end
crescent
two
membran
could
resolv
fig
well
membran
loop
connect
two
bilay
fig
c
crescent
assembl
spheric
immatur
virion
also
electrondens
spicul
membran
nagayama
et
al
morgan
mani
imag
thin
eponor
cryosect
suggest
two
membran
within
immatur
virion
fig
f
small
subpopul
immatur
virion
show
distinct
inner
membran
separ
outer
one
two
membran
inv
regular
spikelik
array
usual
evid
whether
ident
spicul
immatur
virion
unclear
format
inv
particl
becom
enwrap
cellular
membran
cisterna
ichihashi
et
al
morgan
hiller
weber
thu
acquir
third
fourth
membran
simultan
refer
result
fourmembran
viral
form
intracellular
envelop
viru
iev
cryosect
could
easili
identifi
viral
particl
four
distinct
membran
fig
ce
wherea
epon
section
innermost
membran
could
clearli
visual
fig
b
outer
envelop
iev
thought
fuse
plasma
membran
therebi
releas
eev
medium
morgan
payn
kristensson
cryosect
sucros
gradientpurifi
virion
show
morpholog
name
two
membran
within
inv
fig
f
three
within
eev
shown
summari
cryosect
reveal
addit
membran
within
viral
particl
poorli
resolv
epon
section
name
two
membran
immatur
virion
inv
four
membran
iev
three
membran
eev
character
viru
assembl
detail
use
journal
cell
biolog
volum
antibiot
rifampicin
synchron
assembl
process
rifampicin
revers
block
viru
assembl
without
interf
viral
dna
replic
protein
synthesi
moss
et
al
lead
accumul
rifampicin
bodi
larg
electrondens
structur
surround
irregularli
shape
smooth
membran
biochem
studi
shown
rifarnpicin
bodi
contain
sever
vaccinia
structur
protein
payn
kristensson
infect
bhk
hela
cell
incub
presenc
rifampicin
place
drugfre
media
variou
time
fixat
h
pi
chaseperiod
rifampicin
bodi
easili
detect
light
microscopi
use
phasecontrast
fig
b
electron
micrograph
show
structur
partial
surround
irregularli
shape
smooth
membran
fig
c
upon
remov
rifampicin
viral
assembl
proce
normal
moss
et
al
crescentshap
bud
aros
synchron
way
rifampicin
bodi
within
min
h
chase
spheric
immatur
virion
enrich
h
chase
inv
appear
shown
observ
support
previou
studi
propos
rifampicin
bodi
contain
precursor
vaccinia
membran
grimley
et
al
nagayama
et
al
therefor
use
dfampicin
order
accumul
vaecinia
precursor
membran
synchron
viru
assembl
infect
cell
em
studi
consist
current
model
vaccinia
assembl
dale
mosshach
dale
pogo
palad
petterson
two
reason
first
de
novo
model
account
continu
assembl
virion
cellular
membran
second
explain
acquisit
two
membran
inv
could
think
two
altern
hypothes
would
consist
data
first
would
viru
bud
cellular
compart
therebi
acquir
first
membran
form
immatur
viru
sub
figur
viral
crescent
continu
cistern
tubular
membran
epon
section
ae
vvwr
infect
hela
cell
plasma
membran
permeabil
h
infect
use
bacteri
toxin
streptolysin
slo
deplet
cytoplasm
compon
lead
increas
membran
contrast
condit
membran
continu
membran
oftb
viral
crescent
cistern
tubular
cellular
membran
becom
evid
two
tubul
small
arrowhead
appear
eman
electrondens
membran
structur
continu
larg
arrowhead
characterist
round
profil
viral
crescent
larg
arrow
c
indic
continu
rer
membran
tubul
ribosom
rer
indic
small
arrow
c
arrowhead
point
continu
viral
crescent
cellular
membran
incub
ice
bsagold
b
proteinas
k
ce
bsa
gold
readi
access
cytoplasm
well
immatur
virion
asterisk
side
crescent
shape
membran
contrast
gold
particl
exclud
lumen
identifi
cellular
organdi
includ
nuclear
envelop
er
arrowhead
small
fraction
immatur
virion
contain
bsa
gold
star
bsa
gold
also
access
space
inv
wrap
membran
lumen
cisterna
b
proteinas
k
ce
lead
dramat
chang
morpholog
immatur
virion
asterisk
ce
immatur
virion
appear
empti
two
membran
trilarninar
appear
arrowhead
ce
becom
visibl
content
immatur
virion
remain
star
e
virion
morpholog
membran
chang
assum
virion
fulli
close
particl
particl
two
membran
visual
n
nucleu
bar
n
sequent
bud
organel
thu
obtain
second
membran
form
inv
assembl
mechan
immatur
virion
would
contain
one
membran
would
local
within
lumen
organel
altern
viru
could
acquir
two
membran
within
singl
step
becom
envelop
membran
cisterna
mechan
would
predict
immatur
virion
contain
two
membran
free
cytoplasm
rather
lumen
cellular
organel
obtain
better
membran
visual
infect
hela
cell
permeabil
h
pi
use
bacteri
toxin
slo
bhakdi
tranumjensen
ahnerthilg
et
al
cell
treat
rifampicin
chase
h
accumul
viral
crescent
prior
slo
treatment
embed
epon
permeabil
led
signific
extract
cytoplasm
protein
lactat
dehydrogenas
increas
membran
contrast
allow
better
visual
membran
tubul
condit
continu
viral
crescent
cytoplasm
membran
becam
obviou
specif
viral
crescent
appear
continu
either
doubl
membran
cisterna
distinct
tubular
element
fig
tubul
uniform
diamet
nm
thinner
averag
thick
thin
section
difficult
visual
nonextract
cell
slo
extract
cell
also
evid
least
tubul
continu
rough
er
fig
case
difficult
resolv
two
membran
within
crescent
case
howev
fig
c
imag
obtain
show
clearli
structur
also
consist
two
distinct
bilay
imag
lead
us
propos
cistern
structur
would
organ
topolog
er
golgi
membran
space
two
bilay
repres
ectocytoplasm
compart
next
seri
experi
address
issu
use
electrondens
marker
cytoplasm
infect
hela
cell
gentli
broken
select
perfor
plasma
membran
incub
c
bsa
gold
condit
cell
broken
judg
trypan
blue
stain
em
analysi
show
cell
retain
major
cytoplasm
organel
viral
factori
bsa
gold
free
access
cytoplasm
side
crescent
shape
membran
immatur
virion
fig
small
percentag
immatur
virion
bsa
gold
centr
fig
asterisk
argu
particl
alreadi
complet
seal
gold
particl
exclud
lumen
identifi
cellular
organel
nuclear
envelop
rough
er
fig
golgi
complex
mitochondria
shown
bsa
gold
also
access
space
inv
wrap
membran
lumen
cisterna
fig
b
sinc
experi
argu
assembl
virion
within
cellular
organel
free
cytoplasm
access
proteolyt
digest
broken
cell
broken
ceil
treat
proteinas
k
ice
min
subset
cell
assembl
virion
show
dramat
chang
morpholog
name
two
membran
becam
clearli
visibl
fig
ce
addit
content
virion
complet
remov
agreement
bsagold
data
small
percentag
spheric
immatur
viru
profil
appear
viroplasm
affect
proteas
treatment
fig
e
experi
confirm
immatur
virion
contain
two
membran
consist
wrap
membran
cisterna
addit
small
percentag
immatur
virion
found
steadi
state
fulli
seal
sinc
content
major
suscept
bsagold
proteas
digest
use
seri
character
marker
differ
cellular
compart
determin
membran
continu
viral
crescent
belong
cellular
organdi
new
membran
system
devoid
cellular
protein
induc
vaccinia
infect
found
hrp
intern
last
h
infect
well
spectrum
antibodi
specif
endocyt
organdi
coloc
viral
factori
schmelz
b
sodeik
ericsson
g
hiller
h
shida
e
wolff
g
griflith
manuscript
prepar
sinc
viral
factori
alway
locat
perinuclear
region
cell
investig
marker
golgi
complex
would
label
antisera
either
mannosidas
ii
cismedialgolgi
marker
protein
burk
et
al
baron
garoff
galactosyltransferas
transgolgi
marker
enzym
roth
berger
combin
dnastain
show
viral
factori
coloc
figur
immunofluoresc
microscopi
cellular
marker
protein
golgi
complex
vaccinia
infect
ceil
vvwr
infect
hela
cell
fix
h
infect
permeabil
label
antigalactosyltransferas
follow
rhodamineconjug
goat
antirabbit
antibodi
b
show
correspond
dna
stain
use
fluoresc
dna
dye
label
galactosyltransferas
white
dot
line
indic
correspond
region
b
coloc
viral
factori
identifi
cytoplasm
dna
stain
b
n
nucleu
bar
marker
fig
b
made
observ
use
fluoresc
ctnbdceramid
specif
marker
transgolgitgn
element
pagano
shown
sinc
viral
factori
coloc
marker
endosom
lysosom
golgi
stack
tgn
conclud
membran
immatur
virion
deriv
organel
visual
er
use
antibodi
protein
disulfid
isomeras
pdi
tooz
et
al
solubl
er
protein
integr
membran
protein
rough
er
prehn
et
al
fluoresc
label
experi
use
antipdi
fig
b
figur
immunofluoresc
microscopi
cellular
marker
protein
endoplasm
reticulum
vaceinia
infect
cell
vvwr
infect
hela
ceil
label
antipdi
follow
rhodamineconjug
goat
antimous
antibodi
c
follow
rhodamineconjug
goat
antirabbit
antibodi
b
show
correspond
dna
stain
describ
fig
infect
cell
label
pdi
ssr
c
show
fluoresc
pattern
expect
rough
er
note
label
significantli
lower
region
viral
factori
defin
cytoplasm
dna
stain
arrowhead
b
c
n
nucleu
bar
fig
c
show
reticular
stain
expect
er
howev
er
signal
diminish
region
viral
factori
sinc
could
determin
light
microscopi
whether
label
correspond
er
surround
viral
factori
er
membran
extend
viral
factori
pdi
local
immunoelectron
microscopi
crescent
well
immatur
fig
ac
matur
virion
shown
complet
devoid
label
howev
membran
continu
viral
crescent
label
though
less
strongli
er
cisterna
fig
b
pdi
label
consist
found
close
vicin
golgi
stack
often
extend
one
cisterna
one
side
stack
vaccinia
infect
fig
noninfect
cell
g
griflith
unpublish
data
similar
result
seen
cell
infect
vesicular
stomat
viru
pepperkok
r
j
scheel
h
horstmann
h
p
hauri
g
griffith
e
krei
manuscript
submit
public
well
cell
infect
mous
hepat
viru
krijnselock
j
ericsson
p
j
rottier
g
griflith
manuscript
prepar
rifampicin
treat
sampl
label
associ
vaccinia
precursor
membran
adjoin
rifampicin
bodi
howev
significantli
lower
label
seen
er
fig
e
f
nuclear
envelop
shown
experi
impli
vaccinia
membran
might
deriv
cellular
compart
relat
er
recent
number
marker
protein
describ
local
specif
intermedi
station
biosynthet
pathway
refer
intermedi
compart
salvag
compart
cisgolgi
network
review
hauri
schweizer
mellman
simon
rothman
orci
sarast
kuismanen
refer
compart
intermedi
compart
three
cellular
marker
shown
especi
enrich
organel
small
gtpbind
protein
chavrier
et
al
well
two
integr
membran
protein
unknown
function
schweizer
et
al
sarast
et
al
use
antibodi
protein
local
intermedi
compart
vaccinia
infect
bhk
hela
macrophag
cell
immunofluoresc
experi
use
antibodi
show
weak
label
region
viral
factori
defin
dna
stain
well
extens
label
area
adjoin
viral
factori
fig
b
four
differ
affinitypurifi
rabbit
antibodi
test
two
polyclon
sera
rais
synthet
peptid
correspond
cooh
terminu
two
polyclon
sera
made
bacteri
express
fusion
protein
chavrier
et
al
immunofluoresc
one
antieooh
terminu
one
antifus
protein
sera
gave
viral
factori
fig
c
rifampicin
bodi
label
fig
fand
h
two
sera
gave
label
similar
label
gave
ident
label
pattern
immunoelectron
microscopi
label
obtain
two
anticooh
terminu
sera
coum
block
preincub
sera
specif
synthet
peptid
amino
acid
wherea
unspecif
peptid
amino
acid
effect
doubl
immunofluoresc
experi
shown
confirm
vaccinia
infect
cell
two
four
antibodi
coloc
noninfect
cell
chavrier
et
al
rifampicintr
infect
cell
two
four
antibodi
lesser
extent
fig
eh
local
rifampicin
bodi
contain
vaccinia
precursor
membran
signific
differ
label
pattern
seen
two
class
antibodi
present
unclear
determin
whether
membran
viral
factori
relat
intermedi
compart
perform
immunogold
label
antisera
fig
fig
b
fig
c
label
membran
region
viral
factori
well
membran
continu
assembl
virion
fig
c
antibodi
tubulovesicular
element
often
extend
consider
distanc
golgi
stack
well
one
two
cisterna
one
side
golgi
stack
label
fig
b
hela
b
eh
bhk
c
ceil
extract
saponin
fixat
label
e
c
f
b
g
show
correspond
dna
stain
h
phasecontrast
imag
correspond
e
f
g
infect
cell
label
result
perinuclear
pattern
locat
side
nucleu
viral
factori
defin
cytoplasm
dna
stain
b
contrast
c
coloc
larg
extent
viral
factori
doubl
label
rifampicintr
infect
cell
eh
show
bulk
label
e
chang
rifampicin
wherea
bulk
f
concentr
rifampicin
bodi
identifi
phase
contrast
h
arrow
e
f
h
point
rifampicin
bodi
overlap
label
rifampicin
bodi
occur
predominantli
region
viral
factori
defin
dna
stain
g
n
nucleu
bar
ttm
undertook
quantit
analysi
label
take
electron
micrograph
systemat
fashion
determin
densiti
label
differ
structur
sinc
membran
intermedi
compart
vicin
assembl
virion
often
difficult
visual
decid
quantifi
area
cytoplasm
within
viral
factori
comparison
determin
amount
label
virion
well
nuclei
membran
within
viral
factori
show
averag
gold
particl
wherea
virion
nuclei
goldxm
goldm
respect
virion
nuclei
expect
contain
therefor
consid
label
background
data
show
label
region
viral
factori
three
time
higher
background
valu
sinc
membran
intermedi
compart
compris
fraction
area
viral
factori
micrograph
use
quantit
expect
data
underestim
amount
specif
label
associ
membran
compart
sinc
abund
cellular
marker
protein
intermedi
compart
high
especi
longer
infect
time
host
protein
synthesi
shut
sought
suitabl
marker
express
higher
level
chose
recombin
vaccinia
viru
vvel
express
integr
membran
protein
avian
infecti
bronchiti
viru
ibv
el
macham
rose
control
vaccinia
k
promot
shown
previous
use
bulk
protein
remain
endo
h
sensit
macham
rose
indic
reach
medial
golgi
apparatu
condit
ibv
accumul
membran
structur
close
associ
cissid
golgi
stack
macham
et
al
result
togeth
observ
anoth
coronaviru
mous
hepat
viru
bud
poster
pregolgi
compart
tooz
et
al
krijnselock
j
ericsson
p
j
rottier
g
griffith
manuscript
prepara
figur
immunoelectron
microscopi
cellular
marker
protein
er
vaccinia
infect
cell
thaw
cryosect
vvwr
infect
bhk
h
infect
macrophag
b
h
infect
hela
cell
cf
h
infect
label
antipdi
follow
protein
nm
gold
cell
df
treat
rifampicin
infect
antipdi
label
reveal
sever
ercisterna
er
occasion
extend
viral
factori
occasion
label
pdi
seen
membran
cisterna
close
proxim
viral
crescent
cr
especi
macrophag
b
gener
membran
cisterna
continu
close
proxim
assembl
virion
label
c
pdi
label
also
found
close
proxim
golgi
stack
often
extend
one
cisterna
one
side
stack
rifampicintr
cell
pdi
label
high
ercisterna
arrow
e
f
present
small
amount
membran
surround
rifampicin
bodi
r
arrowhead
e
f
cr
crescent
e
immatur
viru
r
rifampicin
bodi
er
endoplasm
reticulum
golgi
complex
bar
nm
tion
would
argu
bulk
ibv
resid
pregolgi
compart
presum
intermedi
compart
two
advantag
use
unlik
ibv
glycoprotein
integr
membran
protein
compar
express
high
level
vvei
infect
cell
immunofluoresc
experi
use
hela
cell
ibv
coloc
perinuclear
region
v
ell
occasion
discret
punctat
structur
peripheri
cell
fig
b
compar
fig
b
ibv
fig
show
less
label
peripher
part
cell
restrict
ibv
label
especi
evid
cell
cycloheximid
present
last
h
infect
chase
much
ibv
possibl
er
shown
presenc
rifampicin
bulk
ibv
also
accumul
perinnclear
locat
addit
lower
label
rifampicin
bodi
contain
vaccinia
precursor
membran
fig
ce
experi
suggest
vaccinia
membran
deriv
membran
contain
abundantli
express
protein
retain
earli
biosynthet
compart
doubleimmunogold
label
experi
use
infect
hela
cell
show
ibv
coloc
larg
extent
smooth
membran
locat
close
nuclear
envelop
golgi
stack
well
one
two
cisterna
cissid
golgi
stack
fig
strong
label
obtain
smooth
membran
within
viral
factori
close
proxim
assembl
virion
fig
b
howev
mani
vaccinia
crescent
membran
continu
membran
label
marker
next
compar
local
ibv
vaccmiainfect
cell
accumul
viral
crescent
immatur
virion
use
mous
macrophag
infect
presenc
rifampicin
chase
min
singlelabel
experi
antiibv
label
mani
smooth
membran
connect
viral
bud
form
rifampicin
bodi
fig
doublelabel
experi
show
coloc
ibv
smooth
membran
around
rifampicin
bodi
fig
b
c
mani
membran
continu
assembl
virion
fig
b
larg
arrow
collect
data
argu
membran
within
viral
factori
induc
vaccinia
infect
rather
belong
intermedi
compart
host
cell
furthermor
contrast
appear
restrict
local
vaccinia
virion
assembl
region
close
golgi
complex
continu
ibv
enrich
membran
vaccinia
viru
realli
assembl
cellular
compart
viral
lipid
composit
reflect
lipid
composit
compart
therefor
determin
phospholipid
composit
cesium
chlorid
gradientpurifi
inv
eev
prepar
compar
whole
cell
tabl
lipid
composit
cell
similar
publish
composit
wherrett
huter
stern
dale
van
meer
simon
compar
whole
cell
extract
inv
rel
defici
sphingomyelin
phosphatidylserin
enrich
phosphatidylinositol
sinc
sphingomyelin
thought
synthes
cismedialgolgi
apparatu
futerman
et
al
jeckel
et
al
low
concentr
inn
would
consist
assembl
compart
posit
golgi
stack
er
fleischer
et
al
van
meer
contrast
compar
whole
cell
extract
well
inv
purifi
eev
enrich
sphingomyelin
phosphatidylserin
rel
low
phosphatidylinositol
composit
similar
late
compart
secretori
rout
van
meer
note
previous
stern
dale
hiller
et
al
inv
form
vaccinia
viru
enrich
phospholipid
ran
close
solvent
front
thin
layer
plate
lipid
tent
identifi
acylbi
monoacylglyceryl
phosphat
hiller
et
al
lipid
relat
lysosom
lipid
bi
monoacylglyceryl
phosphat
wherrett
huter
howev
previou
work
hiller
et
al
enrich
lipid
alway
accompani
decreas
concentr
phosphatidylethanolamin
present
test
possibl
unknown
lipid
product
modif
phosphatidylethanolamin
nacylphosphatidylethanolamin
lipid
observ
structur
similar
acylbi
monoacylglyceryl
phosphat
somerharju
renkonen
figur
immunoelectron
microscopi
cellular
marker
protein
intermedi
compart
er
golgi
complex
vaccinia
infect
cell
thaw
cryosect
vvwr
infect
hela
cell
h
infect
label
b
follow
protein
agold
arrow
point
two
membran
within
assembl
virion
smooth
membran
continu
virion
arrowhead
label
membran
part
continu
assembl
virion
asterisk
well
membran
within
viral
factori
arrowhead
b
label
membran
close
proxim
assembl
virion
asterisk
note
associ
gold
particl
one
cisterna
golgi
complex
g
b
c
show
thaw
cryosect
mous
macrophag
infect
recombin
incub
presenc
rifampicin
h
follow
rain
without
rifampicin
accumul
immatur
viral
particl
section
label
follow
protein
agold
arrow
c
point
two
membran
within
assembl
virion
smooth
membran
continu
virion
note
membran
c
arrow
label
arrowhead
appear
continu
membran
assembl
virion
asterisk
doubl
membran
latter
visibl
small
region
viral
crescent
arg
arrow
show
continu
two
membran
assembl
virion
smooth
membran
tubul
cisterna
arrow
label
arrowhead
bar
nm
figur
immunofluoresc
microscopi
ibv
express
hela
cell
hela
cell
infect
recombin
absenc
b
presenc
rifampicin
ce
label
antiibv
c
b
fluorescem
dna
dye
e
show
correspond
phase
contrast
imag
c
e
infect
cell
show
strong
perinuclear
label
peripher
punctat
structur
b
note
ibv
label
restrict
region
within
infect
cell
compar
b
presenc
rifampicin
ce
ibv
show
similar
perinuclear
label
rifampicin
bodi
arrowhead
c
also
label
although
lesser
extent
rifampicin
bodi
occur
predominantli
region
viral
factori
defin
dna
stain
e
n
nucleu
bar
thought
mani
year
poxvirida
acquir
first
lipid
envelop
de
novo
biogenesi
dale
pogo
palad
petterson
hypothesi
deriv
detail
electron
microscop
studi
plastic
embed
specimen
fail
detect
continu
membran
assembl
virion
cellular
organel
dale
pogo
moss
present
studi
use
thaw
cryosect
antibodi
figur
immunoelectron
microscopi
ibv
express
hela
cell
thaw
cryosect
hela
ceil
infect
recombin
h
h
b
label
antiibv
follow
protein
nm
gold
follow
protein
nm
gold
antiibv
follow
protein
nm
gold
b
show
coloc
ibv
arrow
nm
gold
arrowhead
nm
gold
tubulovesicular
membran
close
nuclear
envelop
golgi
complex
g
well
one
two
cisterna
one
side
golgi
complex
membran
within
viral
factori
immatur
virion
asterisk
assembl
label
ibv
b
n
nucleu
bar
nm
sever
cellular
antigen
show
membran
assembl
virion
alway
proxim
often
continu
smooth
tubulovesicular
membran
intermedi
compart
er
golgi
stack
virion
never
label
cellular
marker
protein
look
result
suggest
vaccinia
membran
synthes
de
novo
deriv
intermedi
compart
host
cell
idea
support
phospholipid
composit
newli
form
virion
intermedi
known
membran
composit
er
later
secretori
compart
van
meer
data
show
four
differ
marker
intermedi
compart
er
golgi
stack
name
restrict
fashion
ibv
el
local
cellular
membran
within
viral
factori
continu
membran
assembl
vaccinia
virion
collect
data
suggest
membran
immatur
virion
deriv
intermedi
compart
clear
studi
membran
intermedi
compart
extens
structur
complex
tubulovesicular
organ
much
surfac
area
consist
smooth
tubul
assum
correspond
tubular
profil
evid
mani
publish
immunofluoresc
imag
eg
sarast
et
al
schweizer
et
al
lippincottschwartz
et
al
organ
region
especi
obviou
thick
section
cell
impregn
osmium
tetroxid
lindsey
euisman
b
rambourg
clermont
marker
intermedi
compart
test
local
one
two
cisterna
one
side
golgi
stack
well
membran
profil
extend
consider
distanc
golgi
region
infect
paper
uninfect
cell
g
grifiith
unpublish
data
howev
distribut
marker
alter
vaccinia
infect
ceil
exampl
immunofluoresc
microscopi
enrich
differ
region
intermedi
compart
vaccinia
infect
cell
whether
find
reflect
differ
function
domain
organel
intrigu
possibl
determin
inform
avail
organ
function
compart
idea
differ
subdomaln
intermedi
compart
support
observ
ibv
restrict
local
compar
site
vaccinia
assembl
well
immatur
virion
assembl
close
proxim
golgi
stack
continu
ibv
enrich
membran
ibv
previous
consid
behav
golgi
resid
protein
macham
et
al
howev
data
show
much
protein
coloc
argu
least
express
vaccinia
infect
cell
ibv
either
exclus
intermedi
compart
intermedi
compart
cisgolgi
boundari
two
compart
defin
doublelabel
studi
carri
directli
compar
local
intermedi
compart
marker
bona
fide
resid
protein
cisgolgi
golgi
mannosidas
one
mechan
vaccinia
could
acquir
membran
intermedi
compart
would
follow
bud
mechan
similar
use
envelop
virus
petterson
griffith
rottier
bud
would
result
acquisit
singl
bilay
would
leav
viru
within
lumen
intermedi
compart
abl
test
hypothesi
introduc
electrondens
marker
bsa
gold
cytoplasm
bsagold
particl
exclud
cellular
compart
clearli
access
side
viral
crescent
well
immatur
matur
virion
propos
therefor
vaccinia
viru
becom
enwrap
membran
cisterna
fig
propos
consist
exist
two
membran
seen
immatur
virion
well
inv
addit
model
explain
immatur
virion
well
inv
acquir
two
membran
still
remain
cytoplasm
think
earli
step
assembl
process
membran
cisterna
tightli
appos
often
difficult
distinguish
two
bilay
two
membran
exist
shown
proteas
treatment
perfor
infect
cell
model
import
question
viral
core
protein
present
factori
becom
associ
cellular
membran
intermedi
compart
seem
like
viral
core
protein
bind
far
unidentifi
viral
transmembran
protein
target
intermedi
compart
result
format
crescent
envelop
complet
immatur
viru
v
contain
two
tightli
appos
membran
form
morpholog
distinct
spicul
crescent
well
iv
indic
line
outer
membran
spicul
becom
less
visibl
viru
matur
matur
viru
particl
intermedi
form
seen
two
membran
becom
clearli
visibl
inner
one
acquir
brick
shape
inv
outer
membran
profil
remain
spheric
next
viral
particl
form
invimv
intracellular
nake
viru
intracellular
matur
viru
see
discuss
membran
profil
brick
shape
inv
becom
enwrap
anoth
cellular
cisterna
therebi
form
fourmembran
intracellular
envelop
viru
iev
iev
believ
fuse
plasma
membran
releas
threemembran
extracellular
envelop
viru
eev
medium
note
model
ignor
problem
dna
found
within
intermedi
particl
enter
assembl
viru
subsequ
immatur
virion
se
put
vaccinia
membran
protein
might
use
tool
futur
studi
intermedi
compart
assembl
model
propos
fig
support
presenc
viral
form
intermedi
spheric
immatur
viru
inv
form
share
spheric
appear
immatur
viru
electron
dens
immatur
viru
form
two
membran
becom
visibl
term
intracellular
nake
viru
inv
long
use
refer
matur
infecti
intracellular
vaccinia
viru
addit
mislead
name
impli
viru
lack
lipid
envelop
clearli
case
thu
propos
viru
futur
refer
intracellular
matur
viru
imv
specifi
intracel
figur
immunoelectron
microscopi
ibv
express
mous
macrophag
cell
mous
macrophag
infect
h
incub
presenc
rifampicin
h
without
rifampicin
min
accumul
viral
crescent
asterisk
last
h
infect
cycloheximid
ad
cultur
medium
thaw
cryosect
label
antiibv
follow
protein
run
gold
doubl
label
b
c
antiibv
protein
nm
gold
protein
nm
gold
label
smooth
membran
small
arrow
close
proxim
viral
crescent
arg
arrow
b
indic
membran
crescent
form
rifampicin
bodi
r
doublelabel
experi
b
c
show
coloc
ibv
small
arrow
arrowhead
smooth
membran
around
rifampicin
bodi
r
continu
close
proxim
assembl
virion
arg
arrow
b
bar
nm
lular
locat
well
infecti
natur
viru
particl
summari
data
indic
vaccinia
viru
first
envelop
viru
shown
becom
enwrap
two
membran
simultan
end
result
process
product
infecti
invimv
process
repeat
invimv
engulf
second
cisterna
cellular
origin
second
cisterna
well
molecular
mechan
involv
uniqu
assembl
process
focu
futur
studi
